|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| IBC's Good Validation Practice for Biologicals, Biopharmaceuticals and Synthetic Drugs | ||||||||||||||||
| February 01, 2002 | ||||||||||||||||
|
IBC USA Conferences, Inc., Las Vegas, NV; Boston, MA; Chicago, IL May 9-10, 2002 - June 10-11, 2002 - June 27-28, 2002 This course concentrates on one of the most difficult areas in regulatory compliance, that of ensuring that facilities, systems, processes and analytical test methods involved in the GLP-compliant testing or GMP-compliant manufacture of all types of pharmaceutical products can be validated to the satisfaction of the regulatory agencies. Validation requires that all critical activities affecting the safety, purity or efficacy of the product are properly defined and controlled and are reproducible in performance. Course emphasis is placed upon specific examples drawn from real-life experiences, so as to provide the maximum insight into validation practices acceptable to FDA and other agencies. |
||||||||||||||||
| Organized by: | IBC USA Conferences, Inc. | |||||||||||||||
| Invited Speakers: | Course Instructor: Alex Kanarek, Ph.D., President, Bio-Development Consulting Services |
|||||||||||||||
| Deadline for Abstracts: | - | |||||||||||||||
| Registration: | Five Easy Ways to Register! Phone (508) 616-5550 Fax (508) 616-5522 E-mail reg@ibcusa.com Online www.LifeSciencesInfo.com/2744 IBC USA Conferences, Inc. One Research Drive Suite 400A Westborough, MA 01581-5195 |
|||||||||||||||
| E-mail: | reg@ibcusa.com | |||||||||||||||
| Posted by: | James G. Prudhomme | |||||||||||||||
| Host: | ntserver.ibcusa.com | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||